Funds · 13F filer · Central, Hong Kong, K3

Nan Fung Trinity (hk) Ltd

$1.0B in 55 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+28.9%S&P 500 +20.9%
3y return+68.4%S&P 500 +68.5%
5y return+43.8%S&P 500 +74.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since December 31, 2019: $228 against $232 in the S&P 500.2

Nan Fung Trinity (hk) LtdS&P 500 (SPY)
$80$100$23220192026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
AMDAdvanced Micro Devices Inc$67.8M6.7%−27.8%
Amcor PLCCUSIP G0250X149$52.0M5.1%+7.5%
PPGPpg Inds Inc$48.2M4.8%
GEHCGe Healthcare Technologies I$40.9M4.0%+202.7%
NVDANvidia Corporation$36.1M3.6%−21.7%
HDHome Depot Inc$35.2M3.5%+37.4%
KTKt Corp$33.8M3.3%
EIDOIshares Tr$33.7M3.3%+33.3%
MBBIshares Tr$33.0M3.3%
OCOwens Corning New$29.6M2.9%+37.0%
UNHUnitedhealth Group Inc$28.4M2.8%−34.4%
APDAir Products And Chemicals I$28.3M2.8%
IJHIshares Tr$27.7M2.7%
AMXAmerica Movil Sab De Cv$27.4M2.7%−20.2%
MIRMMirum Pharmaceuticals Inc$27.2M2.7%
DHRDanaher Corp Del$24.1M2.4%+28.3%
TRVITrevi Therapeutics Inc$22.6M2.2%+6.2%
METAMeta Platforms Inc$21.0M2.1%+145.8%
PTGXProtagonist Therapeutics Inc$19.7M1.9%
ABVXAbivax Sa$18.9M1.9%+10.2%
XHBSpdr Series Trust$17.9M1.8%
JDJd.com Inc$16.6M1.6%
BBIOBridgebio Pharma Inc$16.3M1.6%
MPMp Materials Corp$15.9M1.6%
PDDPdd Holdings Inc$15.8M1.6%+35.8%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
AMDAdvanced Micro Devices IncSeptember 30, 2025+259.1%$67.8M
BCAXBicara Therapeutics IncJune 30, 2025+219.6%$12.7M
MIRMMirum Pharmaceuticals IncJune 30, 2025+130.0%$27.2M
IMNMImmunome IncJune 30, 2025+127.8%$15.1M
PTGXProtagonist Therapeutics IncJune 30, 2025+121.8%$19.7M
TRVITrevi Therapeutics IncSeptember 30, 2025+103.8%$22.6M
XENEXenon Pharmaceuticals IncJune 30, 2025+92.8%$15.0M
NVDANvidia CorporationMarch 31, 2025+84.6%$36.1M
ABVXAbivax SaSeptember 30, 2025+57.0%$18.9M
SRRKScholar Rock Hldg CorpSeptember 30, 2025+47.7%$15.7M

Sold off last quarter

  • THDIshares Inc was $35.4M
  • Honeywell Intl IncCUSIP 438516106 was $19.0M
  • PINSPinterest Inc was $12.1M
  • TGTTarget Corp was $11.7M
  • MCHPMicrochip Technology Inc. was $11.0M
  • ORCLOracle Corp was $9.7M
  • AKRAcadia Rlty Tr was $8.8M
  • FRTFederal Rlty Invt Tr New was $6.8M
  • Soleno Therapeutics IncCUSIP 834203309 was $4.2M
  • Kalvista Pharmaceuticals IncCUSIP 483497103 was $3.1M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+14.5%+14.8%
March 31, 2026−0.3%−4.6%
December 31, 2025+1.7%+2.4%
September 30, 2025+10.9%+7.8%
June 30, 2025+8.5%+10.5%
March 31, 2025+6.1%−4.6%
December 31, 2024−9.9%+2.1%
September 30, 2024+16.5%+5.4%
June 30, 2024−3.0%+4.0%
March 31, 2024+4.5%+10.0%
December 31, 2023+11.1%+11.2%
September 30, 2023−3.8%−3.6%
June 30, 2023−2.5%+8.3%
March 31, 2023+21.7%+7.0%
December 31, 2022+8.0%+7.1%
September 30, 2022−12.6%−5.3%
June 30, 2022−10.2%−16.5%
March 31, 2022−6.6%−4.9%
December 31, 2021−1.7%+10.7%
September 30, 2021−7.5%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1781880
  2. 2
    Filed July 24, 2026 · accession 0001420506-26-001282